Ramipril (Artere (5 mg)) is an angiotensin-converting enzyme (ACE) inhibitor, used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of ...
This document corrects and replaces the press release that was sent today at 11:52 AM EDT. The Lot number should have read JR2178. The issue: Health Canada is informing Canadians that Apotex ...
This was a prospectively designed analysis of two studies; Prospective, Randomized Investigation of the Safety and Efficacy of Micardis vs Ramipril Using ABPM (PRISMA) I 18 and PRISMA II (no. 502.392 ...
The evidence for the efficacy of ramipril in relieving the symptoms of peripheral arterial disease is very limited. Two small RCTs (Ahimastos et al. 2006, n=40 and Shahin et al. 2013a, n=33) found ...
In patients who have vascular disease or high-risk diabetes without heart failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and morbidity from cardiovascular causes, but the ...
The data were from 837 patients with diabetes and hypertension. Such patients are at an increased cardiovascular risk and, therefore, blood pressure management guidelines recommend a lower blood ...
Ramipril (Hoperam (2.5 mg)) is an angiotensin-converting enzyme (ACE) inhibitor, used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of ...
OTTAWA, ONTARIO, Mar 19, 2012 (MARKETWIRE via COMTEX) -- The issue: Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback